Multifunctional Nanoparticles in Precise Cancer Treatment: Considerations in Design and Functionalization of Nanocarriers
Authors:
- 10 November 2020
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Topics in Medicinal Chemistry
- Vol. 20 (27) , 2427-2441
Abstract
Nanotechnology has revolutionized cancer treatment in both diagnosis and therapy. Since the initial application of nanoparticles (NPs) in cancer treatment, the main objective of nanotechnology was developing effective nanosystems with high selectivity and specificity for cancer treatment and diagnosis. To achieve this, different encapsulation and conjugation strategies along with surface functionalization techniques have been developed to synthesize anticancer drugs loaded NPs with effective targeting to specific tumor cells. The unique physicochemical attributes of NPs make them promising candidates for targeted drug delivery, localized therapies, sensing, and targeting at cellular levels. However, a nanosystem for localized and targeted cancer managements should overcome several biological barriers and biomedical challenges such as endothelial barriers, blood brain barrier, reticuloendothelial system, selective targeting, biocompatibility, acute/chronic toxicity, tumor-targeting efficacy. The NPs for in vivo applications encounter barriers at system, organ, and the cellular level. To overcome these barriers, different strategies during the synthesis and functionalization of NPs should be adapted. Pharmacokinetics and cellular uptake of NPs are largely associated with physicochemical attributes of NPs, morphology, hydrodynamic size, charge, and other surface properties. These properties can be adjusted during different phases of synthesis and functionalization of the NPs. This study reviews the advances in targeted cancer treatment and the parameters influencing the efficacies of NPs as therapeutics. Different strategies for overcoming the biological barriers at cellular, organ and system levels and biomedical challenges are discussed. Moreover, the applications of NPs in preclinical and clinical practice are reviewed.Keywords
Funding Information
- National Natural Science Foundation of China (81560508, 11775280, 81970976)
- Northwest Minzu University (11080316)
- Fundamental Research Funds for the Central Universities (31920190013, 31920190018, 31920180020)
This publication has 177 references indexed in Scilit:
- Design and fabrication of magnetic nanoparticles for targeted drug delivery and imagingAdvanced Drug Delivery Reviews, 2010
- The Pursuit of a Scalable Nanofabrication Platform for Use in Material and Life Science ApplicationsAccounts of Chemical Research, 2008
- Shape Induced Inhibition of Phagocytosis of Polymer ParticlesPharmaceutical Research, 2008
- PEGylation of Nanocarrier Drug Delivery Systems: State of the ArtJournal of Biomedical Nanotechnology, 2008
- Preclinical Studies To Understand Nanoparticle Interaction with the Immune System and Its Potential Effects on Nanoparticle BiodistributionMolecular Pharmaceutics, 2008
- Endocytic mechanisms for targeted drug delivery☆Advanced Drug Delivery Reviews, 2007
- Biodegradable nanoparticles for cytosolic delivery of therapeutics☆Advanced Drug Delivery Reviews, 2007
- Nanofabricated particles for engineered drug therapies: A preliminary biodistribution study of PRINT™ nanoparticlesJournal of Controlled Release, 2007
- Are quantum dots ready for in vivo imaging in human subjects?Discover Nano, 2007
- Semitelechelic HPMA Copolymers Functionalized with Triphenylphosphonium as Drug Carriers for Membrane Transduction and Mitochondrial LocalizationBiomacromolecules, 2006